{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:43:08Z","timestamp":1759333388983,"version":"build-2065373602"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The impact of common hemoglobinopathies, such as sickle cell trait (SCT), on outcomes in adults requiring extracorporeal membrane oxygenation (ECMO) remains understudied. Extracorporeal Life Support Organization registry data was analyzed to assess outcomes of adults with SCT or sickle cell disease (SCD) who underwent venoarterial or venovenous ECMO. Among 215 patients identified, 49 had SCT and 166 had SCD. The prevalence of SCT appeared grossly underestimated. Age-adjusted survival rates for SCT patients were favorable compared with those with SCD for venoarterial (43.5% vs. 19.5%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.04) and venovenous (73.3% vs. 44.8%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.11) ECMO. Bleeding and thrombotic event rates and renal complications in SCT patients were comparable to those with SCD and similar to reported rates in general adult ECMO populations. While our findings suggest that ECMO may be safely used in patients with SCT, further investigation is essential to determine the clinical impact of sickle cell and other hemoglobinopathies on ECMO therapy.<\/jats:p>","DOI":"10.1097\/cce.0000000000001326","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:00:23Z","timestamp":1759266023000},"page":"e1326","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the Outcomes of Extracorporeal Membrane Oxygen Support in Patients With Sickle Cell Trait"],"prefix":"10.1097","volume":"7","author":[{"given":"Kate M.","family":"Willsey","sequence":"first","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Plazak","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Belyayev","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rabin","sequence":"additional","affiliation":[{"name":"Department of Surgery and Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janhavi","family":"Athale","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary and Critical Care Medicine, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Gladwin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Grazioli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary and Critical Care Medicine, Program in Trauma, University of Maryland School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"R1-20250930","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/jcm8070981","article-title":"Incidence and impact of acute kidney injury in patients receiving extracorporeal membrane oxygenation: A meta-analysis.","volume":"8","author":"Thongprayoon","year":"2019","journal-title":"J Clin Med"},{"key":"R2-20250930","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jchf.2020.09.004","article-title":"Hemocompatibility-related adverse events and survival on venoarterial extracorporeal life support: An ELSO registry analysis.","volume":"8","author":"Chung","year":"2020","journal-title":"JACC Heart Fail"},{"key":"R3-20250930","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","article-title":"Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: An ELSO registry analysis.","volume":"48","author":"Nunez","year":"2022","journal-title":"Intensive Care Med"},{"key":"R4-20250930","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5001\/omj.2010.2","article-title":"A review of clinical profile in sickle cell traits.","volume":"25","author":"John","year":"2010","journal-title":"Oman Med J"},{"key":"R5-20250930","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2215\/CJN.0000000000000257","article-title":"Differences in the circulating proteome in individuals with versus without sickle cell trait.","volume":"18","author":"Cai","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-20250930","doi-asserted-by":"crossref","first-page":"916197","DOI":"10.3389\/fphys.2022.916197","article-title":"Plasma levels of acyl-carnitines and carboxylic acids correlate with cardiovascular and kidney function in subjects with sickle cell trait.","volume":"13","author":"Nemkov","year":"2022","journal-title":"Front Physiol"},{"key":"R7-20250930","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2024026899","article-title":"Sickle cell trait does not cause \u201csickle cell crisis\u201d leading to exertion-related death: A systematic review.","volume":"145","author":"Weeks","year":"2025","journal-title":"Blood"},{"key":"R8-20250930","first-page":"bloodadvances.2025016368","article-title":"Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation.","author":"Grazioli","year":"2025","journal-title":"Blood Adv"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:00:24Z","timestamp":1759266024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":8,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001326","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}